JEFFREY HERMANN: Open Payments
NPI 1376603597 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,727 in 147 payments from 16 companies in 2025. Trend: 2023 $1,796 · 2024 $1,994 · 2025 $2,727
Food & beverage: $2,727
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $374 |
| Teva Pharmaceuticals USA, Inc. | 19 | $365 |
| Otsuka America Pharmaceutical, Inc. | 12 | $307 |
| Supernus Pharmaceuticals, Inc. | 18 | $236 |
| Axsome Therapeutics, Inc. | 15 | $224 |
| Alkermes, Inc. | 7 | $219 |
| Collegium Pharmaceutical, Inc. | 13 | $201 |
| Neurocrine BioSciences, Inc. | 9 | $178 |
| Tris Pharma Inc | 10 | $164 |
| Corium, LLC | 13 | $163 |
Products named: CAPLYTA, UZEDY, Qelbree, Auvelity, LYBALVI, Jornay PM, INGREZZA, Dyanavel XR.
Industry payments across PA — which companies pay providers there.
